Tuesday, April 7, 2015


My passion and goal is to have options available in the U.S., Mexico, and Canada, covered by all insurance companies. Stand up to cancer with me and change the health care industry. You are a drop, but together we are an ocean. YOU CAN MAKE A DIFFERENCE ~ LETS CHANGE THE THINKING OF CANCER


Some statistics to think about:
Every 7 minutes a woman is diagnosed with gynecological cancer, 1 million a year in the U.S.
The American Cancer Society’s estimates for breast cancer in women in the United States for 2015 are:
About 231,840 new cases of invasive breast cancer
About 62,290 new cases of carcinoma in situ (CIS) of the breast will be found (CIS is non-invasive and is the earliest form of breast cancer).
About 40,290 deaths from breast cancer
cancer is the most common cancer among women in the United States, other than skin cancer. It is the second leading cause of cancer death in women, after lung cancer.
Annual report, The American Cancer Society
This annual report provides the estimated numbers of new cancer cases and deaths in 2015, as well as current cancer incidence, mortality, and survival statistics and information on cancer symptoms, risk factors, early detection, and treatment. In 2015, THERE WILL BE AN ESTIMATED 1,658,370 NEW CANCER CASES DIAGNOSED and 589,430 cancer DEATHS in the US. (Please note: The projected numbers of new cancer cases and deaths in 2015 should not be compared with previous years to track cancer trends because they are model-based and vary from year to year for reasons other than changes in cancer occurrence. Age-standardized incidence and death rates should be used to measure cancer trends.)
Cancer Research Funding
Key Points
• The National Cancer Institute (NCI), part of the National Institutes of Health and the Department of Health and Human Services, is the Nation’s principal agency for cancer research and coordinates the National Cancer Program.
• As a federal agency, NCI receives its funds from Congress.
• Although NCI’s budget has been relatively flat in recent years, averaging approximately $4.9 billion per year, funding for specific cancer types and research categories may fluctuate for a number of reasons.
• Other federal agencies, state, and local governments, voluntary organizations, private institutions, and industry spend substantial amounts of money on cancer-related research.
source: National Cancer Institute : website.
As I understand it science has mapped the genome for cancer. The problem is that the cancer cell mutates making many drug treatment programs ineffective. Research is very expensive and as drugs become ineffective continuing research must be performed to combat the evolution of the disease driving up costs for treatment. In a great many cases patient’s lives are extended by drugs used to fight their disease until their cancer mutates creating another type of cancer cell requiring another type of drug.
Research is being slowed by a lack of funding.

No comments: